<DOC>
	<DOCNO>NCT01007110</DOCNO>
	<brief_summary>DHA , type fatty acid , important early development , term reproductive physiology gestation postnatal behavioral cognitive function . In adult , DHA show low triglyceride important cardiovascular health autonomic control , lower heart rate blood pressure increase heart variability . Little known fatty acid impact cardiac control infant , child fetus . Our hypothesis maternal DHA supplementation ( 600 mg/day ) low fetal HR increase fetal HRV .</brief_summary>
	<brief_title>Effects Docosahexaenoic Acid ( DHA ) Fetal Cardiac Outcomes</brief_title>
	<detailed_description>We observe maternal DHA supplementation pregnancy result low fetal heart rate ( HR ) high heart-rate variability ( HRV ) . In another study , find infant DHA supplement formula lower HR . Because DHA supplementation infancy associate improved neurobehavioral outcome infant low HR high vagal control find improved developmental outcome , first aim conduct randomize , placebo-controlled trial determine whether maternal DHA supplementation pregnancy result low HR high HRV fetal period . We document fetal neurobehaviors ( body breathe movement ) hallmarks fetal well-being influence HR HRV .</detailed_description>
	<criteria>Pregnant females 16.035.99 year age 12 20 week gestation time enrollment ( date ultrasound ) Agree consume study capsule enrollment delivery BMI &lt; 40 baseline weight exceed 300 pound No serious illness likely confound study outcomes Available phone Less 16 great 35.99 year age enrollment BMI &gt; 40 baseline Any serious illness likely confound primary study outcome Expecting multiple infant Diabetes ( Type I , II gestational ) baseline Elevated blood pressure due cause ( systolic BP &gt; = 140 mm Hg Gestational age baseline &lt; 12 week &gt; 20 week Unable provide inform consent English</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>DHA</keyword>
</DOC>